|
1
|
Ferrari S and Palmerini E: Adjuvant and
neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr
Opin Oncol. 19:341–346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sasaki N, Toda T, Kaneko T, Baba N and
Matsuo M: Protective effects of flavonoids on the cytotoxicity of
linoleic acid hydroperoxide toward rat pheochromocytoma PC12 cells.
Chem Biol Interact. 145:101–116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jackson S and Xiong Y: CRL4s: the
CUL4-RING E3 ubiquitin ligases. Trends Biochem Sci. 34:562–570.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kopanja D, Roy N, Stoyanova T, Hess RA,
Bagchi S and Raychaudhuri P: Cul4A is essential for spermatogenesis
and male fertility. Dev Biol. 352:278–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu L, Lee S, Zhang J, et al: CUL4A
abrogation augments DNA damage response and protection against skin
carcinogenesis. Mol Cell. 34:451–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin Y, Lin C, Kim ST, et al: The E3
ubiquitin ligase Cullin 4A regulates meiotic progression in mouse
spermatogenesis. Dev Biol. 356:51–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Banks D, Wu M, Higa LA, et al: L2DTL/CDT2
and PCNA interact with p53 and regulate p53 polyubiquitination and
protein stability through MDM2 and CUL4A/DDB1 complexes. Cell
Cycle. 5:1719–1729. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Higa LA, Yang X, Zheng J, et al:
Involvement of CUL4 ubiquitin E3 ligases in regulating CDK
inhibitors Dacapo/p27Kip1 and cyclin E degradation. Cell Cycle.
5:71–77. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nishitani H, Shiomi Y, Iida H, Michishita
M, Takami T and Tsurimoto T: CDK inhibitor p21 is degraded by a
proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway
during S phase and after UV irradiation. J Biol Chem.
283:29045–29052. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schindl M, Gnant M, Schoppmann SF, Horvat
R and Birner P: Overexpression of the human homologue for
Caenorhabditis elegans cul-4 gene is associated with poor
outcome in node-negative breast cancer. Anticancer Res. 27:949–952.
2007.
|
|
11
|
Singhal S, Amin K, Kruklitis R, et al:
Alterations in cell cycle genes in early stage lung adenocarcinoma
identified by expression profiling. Cancer Biol Ther. 2:291–298.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tarpey PS, Raymond FL, O’Meara S, et al:
Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit,
cause an X-linked mental retardation syndrome associated with
aggressive outbursts, seizures, relative macrocephaly, central
obesity, hypogonadism, pes cavus, and tremor. Am J Hum Genet.
80:345–352. 2007. View
Article : Google Scholar
|
|
13
|
Zou Y, Liu Q, Chen B, et al: Mutation in
CUL4B, which encodes a member of cullin-RING ubiquitin ligase
complex, causes X-linked mental retardation. Am J Hum Genet.
80:561–566. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Y, Liu R, Qiu R, et al: CRL4B
promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in
DNA methylation-based epigenetic silencing. Oncogene. Dec
2–2013.(Epub ahead of print). doi: 1038/onc.2013.522.
|
|
15
|
Nakagawa T and Xiong Y: X-linked mental
retardation gene CUL4B targets ubiquitylation of H3K4
methyltransferase component WDR5 and regulates neuronal gene
expression. Mol Cell. 43:381–391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zou Y, Mi J, Cui J, et al:
Characterization of nuclear localization signal in the N terminus
of CUL4B and its essential role in cyclin E degradation and cell
cycle progression. J Biol Chem. 284:33320–33332. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu H, Yang Y, Ji Q, et al: CRL4B catalyzes
H2AK119 monoubiquitination and coordinates with PRC2 to promote
tumorigenesis. Cancer Cell. 22:781–795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aggarwal P, Lessie MD, Lin DI, et al:
Nuclear accumulation of cyclin D1 during S phase inhibits
Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA
rereplication. Genes Dev. 21:2908–2922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koepp DM, Harper JW and Elledge SJ: How
the cyclin became a cyclin: regulated proteolysis in the cell
cycle. Cell. 97:431–434. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Levine AJ, Momand J and Finlay CA: The p53
tumour suppressor gene. Nature. 351:453–456. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jia S, Kobayashi R and Grewal SI:
Ubiquitin ligase component Cul4 associates with Clr4 histone
methyltransferase to assemble heterochromatin. Nat Cell Biol.
7:1007–1013. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Horn PJ, Bastie JN and Peterson CL: A
Rik1-associated, cullin-dependent E3 ubiquitin ligase is essential
for heterochromatin formation. Genes Dev. 19:1705–1714. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dumbliauskas E, Lechner E, Jaciubek M, et
al: The Arabidopsis CUL4-DDB1 complex interacts with MSI1 and is
required to maintain MEDEA parental imprinting. EMBO J. 30:731–743.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Buckbinder L, Talbott R, Velasco-Miguel S,
et al: Induction of the growth inhibitor IGF-binding protein 3 by
p53. Nature. 377:646–649. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams AC, Collard TJ, Perks CM, et al:
Increased p53-dependent apoptosis by the insulin-like growth factor
binding protein IGFBP-3 in human colonic adenoma-derived cells.
Cancer Res. 60:22–27. 2000.
|
|
26
|
Hanafusa T, Shinji T, Shiraha H, et al:
Functional promoter upstream p53 regulatory sequence of IGFBP3 that
is silenced by tumor specific methylation. BMC Cancer. 5:92005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nag A, Bagchi S and Raychaudhuri P: Cul4A
physically associates with MDM2 and participates in the proteolysis
of p53. Cancer Res. 64:8152–8155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dairkee SH and Smith HS: Genetic analysis
of breast cancer progression. J Mammary Gland Biol Neoplasia.
1:139–151. 1996. View Article : Google Scholar : PubMed/NCBI
|
